Labarai
Muhimmancin Asibiti na Bands na Oligoclonal Protein Bayan Maganin BCMA CAR-T ga Marasa Lafiya da yawa na Myeloma
Wani bincike da aka yi a baya ya kimanta faruwar da tasirin ƙwayoyin furotin na oligoclonal (APB) a cikin marasa lafiya da suka sake komawa baya/rashin amsawa ga myeloma da yawa (MM) waɗanda aka yi wa magani da LCAR-B38M CAR-T, yana nuna alaƙarsu da ingantattun sakamako.
Labarin Marasa Lafiya: Daga Ganewar AML-M2 zuwa Ɗalibi na Farko a Jami'a - Tafiya ta Shekaru Biyar zuwa Murmurewa
Wani matashin majiyyaci mai fama da cutar sankarar jini wanda ya shafe shekaru biyar yana fama da cutar AML-M2, wanda ya kai ga nasarar dashen ƙwayoyin halitta masu kama da haploid a Asibitin Lu Daopei, ya share fagen sabuwar rayuwarsa a matsayin ɗalibi a jami'a.
Nazarin Cibiyoyin Daban-daban Ya Nuna Kyakkyawan Hasashe Ga Marasa Lafiyar Jini Da Ke Yin Dashen Kwayoyin Halittar Allogeneic Tare Da ATG
Wani babban bincike da aka gudanar a wurare da dama a kasar Sin ya nuna sakamako mai kyau ga marasa lafiya da ke fama da cututtukan jini da aka yi wa dashen ƙwayoyin halitta marasa alaƙa da juna (MMUD) tare da ATG don rigakafin GVHD.
Labarin Marasa Lafiya: Babban Hadarin B-ALL, Dashen Maƙogwaro a Watanni 9, Shekaru Biyu Bayan Haka—Farawa Mai Kyau ga Matasan Masoya
An yi wa wani yaro ɗan wata 9 da haihuwa da aka gano yana da cutar Acute B Lymphoblastic Leukemia (B-ALL), tiyatar dashen ƙashi mai kyau. Shekaru biyu bayan haka, yaron yana cikin koshin lafiya kuma a shirye yake ya fara zuwa makarantar yara.
Haɓaka Shirye-shiryen Kwayoyin CAR-T don Inganta Sakamakon Marasa Lafiya
Wani bita na baya-bayan nan a cikin Nazarin Haihuwar Lancet yana nuna ci gaba mai kyau a fannin maganin ƙwayoyin CAR-T, yana mai da hankali kan inganta saurin samarwa, inganta ingancin magani, da kuma faɗaɗa isa ga marasa lafiya da ke fama da jini da ciwon daji.
Maganin Brexu-cel CAR-T Ya Nuna Sakamako Mai Kyau Ga Marasa Lafiyar R/R Na Manya
Wani bincike da aka yi kwanan nan a cikin Mujallar Ciwon Kankara ta Asibiti yana ba da rahoton sakamako mai kyau ga maganin CD19 CAR-T brexucabtagene autoleucel (brexu-cel) wajen magance cutar sankarar lymphoblastic mai saurin kamuwa da cutar B-cell (R/R B-ALL), yana ba da bege ga yawan gafara da ingantaccen rayuwa a yanayin duniya na ainihi.
Fahimtar Thalassemia: Jagora Mai Cikakke ga Siffofin Alpha da Beta
Cutar Thalassemia cuta ce da ta fi kowacce cuta. Wannan jagorar ta yi nazari kan alpha da beta thalassemia, musabbabinta, alamominta, da kuma sabbin hanyoyin magani da ake da su a Cibiyar Kiwon Lafiya ta Duniya ta BIOOCUS.
Daga Rashin Tsarin Dashen Farko zuwa Cikakken Murmurewa: Tafiyar Majiyyaci tare da Tsarin Dashen Farko na Lu Daopei
Bayan an gano cewa akwai cutar sankarar jini ta B-lymphoblastic mai tsanani da kuma gazawar dashen farko, hanyar murmurewa ta majiyyaci ta yi kama da ba ta da kyau. Duk da haka, ta hanyar ƙwarewar ƙungiyar likitocin Lu Daopei da kuma wani dashen na biyu daga wani mai ba da gudummawa wanda ba dangi ba ne, bege da lafiya sun dawo.
Rayuwa Kan Matsalolin Da Ke Faruwa: Tafiya Ta Shekaru 14 Ta Juriya A Yaƙi Da Ciwon Mara Mai Na Mataki Na IV
Jennifer Ficko, wacce aka gano tana da cutar melanoma a mataki na IV tana da shekaru 48, ta ƙi amincewa da duk wani tsammani. Ta hanyar magunguna masu ban mamaki kamar maganin TIL da kuma goyon bayan iyalinta, ta kasance ba ta da cutar kansa tsawon shekaru sama da bakwai, tana murnar shekaru 14 da ta tsira.
Cin Nasara Kan Ciwon Daji: Tafiyar Wata Yarinya Ta Juriya Da Fata A Asibitin Lu Daopei
A shekarar 2016, an gano wata yarinya 'yar shekara 11, Wenwen (wanda aka fi sani da suna), tana da cutar sankarar jini mai tsanani ta ƙwayoyin T-cell lymphoblastic leukemia. Tana fuskantar ƙalubale masu barazana ga rayuwa, ita da iyalinta sun nemi magani a Asibitin Lu Daopei. A yau, bayan nasarar dashen dashen da aka yi mata da kuma shekaru da suka gabata na murmurewa, tana samun ci gaba kuma tana shirin jarrabawar shiga jami'a.
Maganin Kwayoyin Halitta na NK da aka haɗa tare da allurar rigakafin DC ya nuna babban ci gaba a cikin cutar kansar hanta ta ƙarshe
An samu ci gaba a fannin maganin ciwon hanta mai tsanani ta hanyar sabon haɗin maganin ƙwayoyin NK, allurar rigakafin DC, da kuma Nivolumab. Wannan haɗin gwiwar rigakafi ya nuna babban nasara, wanda ya haifar da raguwar ƙari da inganta aikin hanta cikin makonni shida kacal ga majiyyaci da ke fama da cutar kansar hanta ta ƙarshen lokaci.
Dr. Lu Peihua Ya Gabatar Da Nasarar Ci Gaba A Fannin Maganin CAR-T A Taron Shekara-shekara na APBMT na 29
A taron shekara-shekara na 29 na Asiya da Pacific na dashen jini da maƙogwaro (APBMT), Dr. Lu Peihua ta gabatar da jawabi mai muhimmanci kan nasarar maganin ƙwayoyin cuta na CAR-T a China. Bayanan ƙungiyarta na zahiri daga ayyukan asibiti sun sami yabo daga ƙasashen duniya, inda suka nuna gudummawar da suka bayar wajen magance cututtukan da ke haifar da cutar jini.